This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Saglio G, Guerrasio A, Rosso C, Zaccaria A, Tassinari A, Serra A et al. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1990; 76: 1819–1824.
Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410–2414.
Briz M, Vilches C, Cabrera R, Fores R, Fernandez MN . Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript. Blood 1997; 90: 5024–5025.
How GF, Tan LT, Lim LC . Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction – is it truly a benign disease? Leukemia 1998; 12: 1166–1167.
Polak J, Koza V, Cetkovsky P, Haskovec C . An accelerated-phase CML patient with e19a2 junction of BCR/ABL gene – the first case of transplanted CML with micro bcr. Bone Marrow Transplant 2000; 25: 1109–1110.
Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031–1037.
Kim YJ, Kim DW, Lee S, Kim HJ, Kim YL, Hwang JY et al. Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the bcr-abl gene after hematopoietic stem cell transplantation in CML. Eur J Haematol 2002; 68: 272–280.
Cross NC, Melo JV, Feng L, Goldman JM . An optimized multiplex polymerase chain reaction for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 1994; 8: 186–189.
Acknowledgements
This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (01-PJ10-PG6-01GN16-0005).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, JJ., Kim, HJ., Kim, YJ. et al. Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts. Leukemia 18, 1539–1540 (2004). https://doi.org/10.1038/sj.leu.2403454
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403454